Gorham-Stout Syndrome with Focal Segmental Glomerulosclerosis: A Case Report
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Gorham-Stout syndrome is a rare bone disorder characterized by progressive massive osteolysis and proliferation of vascular and lymphatic vessels. A 15-yearold boy was initially diagnosed with Gorham-Stout at the age of 8 years based on clinical and radiological findings. Following diagnosis, he was treated with pamidronate, interferon alfa, propranolol, oral corticosteroids, and sirolimus. He developed proteinuria at the age of 15 and progressed into the nephrotic range 2 years later. A renal biopsy revealed focal segmental glomerulosclerosis, not otherwise specified variant. The sequential increase in proteinuria associated with medications suggested that the focal segmental glomerulosclerosis may be caused by pamidronate and sirolimus, but cannot completely rule out the possibility of kidney involvement of GSS itself.
Abstract
Gorham-Stout syndrome is a rare bone disorder characterized by progressive massive osteolysis and proliferation of vascular and lymphatic vessels. A 15-yearold boy was initially diagnosed with Gorham-Stout at the age of 8 years based on clinical and radiological findings. Following diagnosis, he was treated with pamidronate, interferon alfa, propranolol, oral corticosteroids, and sirolimus. He developed proteinuria at the age of 15 and progressed into the nephrotic range 2 years later. A renal biopsy revealed focal segmental glomerulosclerosis, not otherwise specified variant. The sequential increase in proteinuria associated with medications suggested that the focal segmental glomerulosclerosis may be caused by pamidronate and sirolimus, but cannot completely rule out the possibility of kidney involvement of GSS itself.
참고문헌 (15)
- Liu Y, "Gorham-Stout disease: radiological, histological, and clinical features of 12 cases and review of literature", Clin Rheumatol, 35, pp.813~823 (2016)
- Al Kaissi A, "The diagnosis and management of patients with idiopathic osteolysis", Pediatr Rheumatol, 9 (2011)
- Hardegger F, "The syndrome of idiopathic osteolysis classification, review, and case report", J Bone Joint Surg Br, 67, pp.88~93 (1985)
- Zankl A, "Multicentric carpotarsal osteolysis is caused by mutations clustering in the amino-terminal transcriptional activation domain of MAFB", Am J Hum Genet, 90, pp.494~501 (2012)
- Barri YM, "Podocyte injury associated glomerulopathies induced by pamidronate", Kidney Int, 65, pp.634~641 (2004)
- Rosenberg AZ, "Focal Segmental Glomerulosclerosis", Clin J Am Soc Nephrol, 12, pp.502~517 (2017)
- Perazella MA, "Bisphosphonate nephrotoxicity", Kidney Int, 74, pp.1385~1393 (2008)
- 윤주영, "Gorham 병으로 진단된 9세 남아에서 파미드로네이트 치료 경험 1례", Annals of Pediatric Endocrinology & Metabolism, 16(3), pp.189~192 (2011), 대한소아내분비학회
- Hammer F, "Gorham-Stout disease-stabilization during bisphosphonate treatment", J Bone Miner Res, 20, pp.350~353 (2005)
- Letavernier E, "High sirolimus levels may induce focal segmental glomerulosclerosis de novo", Clin J Am Soc Nephrol, 2, pp.326~333 (2007)
- Letavernier E, "Sirolimus interacts with pathways essential for podocyte integrity", Nephrol Dial Transplant, 24, pp.630~638 (2009)
- Cho ME, "Sirolimus therapy of focal segmental glomerulosclerosis is associated with nephrotoxicity", Am J Kidney Dis, 49, pp.310~317 (2007)
- Markowitz GS, "Treatment with IFN-alpha, -beta, or -gamma is associated with collapsing focal segmental glomerulosclerosis", Clin J Am Soc Nephrol, 5, pp.607~615 (2010)
- Klein C, "Multicentric carpotarsal osteolysis syndrome : long-term follow-up of three patients", Skeletal Radiol, 47, pp.1015~1019 (2018)
- Moriguchi T, "MAFB Is essential for renal development and F4", 80expression in macrophages, 2006, pp.26, 5715~5727